Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-10-09

Clinical Trial Update: Valproic Acid in Subjects With Intact Cognition - Proof of Concept Study [EARLY_Phase 1]

View source ↗

Summary

Proof-of-concept Phase 1 trial evaluating valproic acid in subjects with intact cognition related to Alzheimer's disease; trial completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VALPROIC ACID (Valproic acid)

Snippet

Sponsor: Gregory Jicha, 323-5550 | Conditions: Alzheimer's Disease | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2019-10-09